Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT05304858 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2025-04-25
Summary
The purpose of this study is to collect prostate cancer tissue from males with metastatic prostate cancers in order to study the tumor microenvironment (TME), which is the area surrounding the tumor including cells, blood vessels, etc., in men with metastatic prostate cancer. The type of research performed on these tissue samples include genetic \& molecular analyses.
Conditions
- Recurrent Prostate Cancer
Interventions
- PROCEDURE
-
Biopsy
Standard of care surgical procedures to collect prostate cancer tissue from men with metastatic prostate cancers. Non-experimental.
Sponsors & Collaborators
-
Janssen Pharmaceuticals
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Mark N. Stein, MD · Columbia University
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-15
- Primary Completion
- 2028-02-29
- Completion
- 2028-02-29
Countries
- United States
Study Locations
More Related Trials
-
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
NCT02853097 ·Status: TERMINATED
-
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
NCT05848050 ·Status: COMPLETED ·Phase: NA
-
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
NCT02080650 ·Status: COMPLETED ·Phase: NA
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
NCT05592925 ·Status: UNKNOWN
-
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
NCT00095589 ·Status: COMPLETED
-
A Multicenter Cancer Biospecimen Collection Study
NCT04510129 ·Status: RECRUITING
-
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
NCT04985357 ·Status: WITHDRAWN
-
NSABP Patient Registry and Biospecimen Profiling Repository
NCT01793805 ·Status: COMPLETED
-
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation
NCT02132858 ·Status: COMPLETED
-
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 ·Status: COMPLETED
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
NCT00806650 ·Status: COMPLETED
-
Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues
NCT01968863 ·Status: TERMINATED
-
Molecular Epidemiology of Lymphoma Patients
NCT00488553 ·Status: WITHDRAWN
-
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
NCT05697198 ·Status: COMPLETED
-
Aberrant Gene Expression Prostate Carcinoma
NCT00868803 ·Status: ACTIVE_NOT_RECRUITING
-
Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells
NCT01286883 ·Status: TERMINATED
-
DNA Changes in Patients With Prostate Cancer
NCT00899184 ·Status: COMPLETED
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED